Author: van der Baan Frederieke H Klungel Olaf H Egberts Antoine CG Leufkens Hubert G Grobbee Diederick E Roes Kit CB Knol Mirjam J
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.12, Iss.10, 2011-10, pp. : 1485-1492
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Prevention Trials: Design and Analysis Considerations
By Drye Lea T. Meinert Curtis L.
Pharmaceutical Medicine, Vol. 25, Iss. 6, 2011-12 ,pp. :
Randomized controlled clinical trials of experimental vaccines
By Naficy A.B. Clemens J.D. Rao M.R.
European Journal of Medicinal Chemistry, Vol. 95, Iss. 4, 1997-10 ,pp. :
Randomized Controlled Trials and Assessment of Drug Safety
Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. :
Warfarin Pharmacogenetics: Economic Considerations
PharmacoEconomics, Vol. 25, Iss. 11, 2007-01 ,pp. :